Celera and Abbott Enter Collaboration to Identify Pharmacogenomic Markers.
Business Wire › November 05, 2008
Linked as:
Business Wire › November 05, 2008
Linked as:Extract
Celera and Abbott Enter Collaboration to Identify Pharmacogenomic Markers.
ALAMEDA, Calif. -- Celera Corporation (NASDAQ:CRA) today announced that it has entered into a research collaboration with Abbott to identify genetic markers for one of Abbott's investigational c...
See the full content of this document
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
zacks #1 rank top performers: conexant systems, turkcell, greenhill & co., sotheby's a... | allergan completes negotiation of terms and conditions of merger agreement with inamed and inamed board of directors has conc... | US Unwired Reports Third Quarter 2003 Financial Results. | advisory/motorcycles roar through denver!; cycle world international motorcycle show presented by toyota trucks; the largest consumer motorcycle sho... | Decisión de Tribunal Sexto de Primera Instancia en Funciones de Control de Sucre (Extensión Cumaná), de December 09, 2010 | Decisión nº 435 de Tribunal Tercero de Primera Instancia en funciones de Control de Merida (Extensión El Vigia), de October 26, 2010 | decisión de tribunal tercero de primera instancia en funciones de control de sucre extensión carupano de october 01 2010 | Decisión nº 3C-3296-10 de Tribunal Tercero de Control Extensión Barlovento de Miranda de ...